Browse treatments

…re, counselling, and adverse drug reaction (ADR) monitoring for chemotherapy patients. Beyond dispensing, pharmacists help patients understa…

…e of the distressing symptoms in patients with cancer receiving chemotherapy. Information about side effects may exacerbate CINV due to the …

…cells. Inhibiting SLC1A3 significantly enhanced the efficacy of chemotherapy plus anti-PD-1, underscoring its potential as a therapeutic tar…

… years, 51.0% reported life completion versus 41.7% in the late chemotherapy group (difference: 9.3 points; 95% CI 6.9 to 11.7). More famili…

…rs (SCs) and sentinel symptoms in patients with lymphoma during chemotherapy treatment and examine the associations between sentinel symptom…

… of life in patients with cancer undergoing or having completed chemotherapy. This study evaluated the efficacy and safety of mirogabalin in…

…solid cancer treated with ICIs compared with those treated with chemotherapy, placebo or no treatment. Risk of bias was evaluated with the C…

…removed anal tumours with margins ≤1 mm will receive lower dose chemoradiotherapy, while participants with anal tumours with margins >1 mm will b…

…en 2020-2023 and received chemo/IO. Among patients treated with immunotherapy, 563 (87.4%) received atezolizumab; 61 (9.5%) received durvalum…

… higher MPO activity in circulating neutrophils correlated with chemotherapy resistance.Conclusions Overall, our study demonstrates the crit…

…ered in pancreatic disease, especially after treatments such as chemotherapy. The goal of this study is to characterize monocyte subsets in …

… Systemic therapies for advanced gastric cancer (GC), including chemotherapy, targeted therapy and immunotherapy, have evolved significantly…